IGEM:MIT/2008/Notebook/Fundraise/Fundraising notes: Difference between revisions
From OpenWetWare
Jump to navigationJump to search
No edit summary |
Chia-Yung Wu (talk | contribs) |
||
Line 22: | Line 22: | ||
* Abbott | * Abbott | ||
** The Abbott fund focuses on geographical areas directly around Abbott facilities. | ** The Abbott fund focuses on geographical areas directly around Abbott facilities. | ||
* National Starch Food Innovation division (They have a plant genetics group, not clear if they have a philanthropy program yet) |
Revision as of 12:57, 3 July 2008
Notes on fund raising for 2008
- Invitrogen Foundation
- Sent an exploratory email to the Invitrogen Foundation on 6/20/2008. They responded by saying that they are reconsidering the goals of their foundation. We could apply but the next review isn't until September.
- AstraZeneca
- They fund healthcare projects, not promising.
- Biogen Idec Foundation
- Submitted an application with their Corporate Responsibility group on 6/27.
- GlaxoSmothKline
- The mission of their philanthropy program focuses on global healthcare. It is unlinely that we qualify.
- Merck
- The Merck Company Foundation does not accept unsolicited requests.
- Infinity Pharmaceuticals
- They don't have an formal sponsorship program. I sent an unsolicited inquiry on 6/20/2008.
- Massachusetts Biotechnology Education Foundation
- Sent an initial contact email using their online form on 6/20/2008.
- Schering-Plough
- Submitted an application on 6/27.
- Genzyme
- Submitted an application with their Community Relations on 6/28.
- Monsanto has a six month turn-around on applications.
- Millenium Pharmaceuticals focuses on patient education and cancer treatment.
- Abbott
- The Abbott fund focuses on geographical areas directly around Abbott facilities.
- National Starch Food Innovation division (They have a plant genetics group, not clear if they have a philanthropy program yet)